"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
“UPR 成分 ATF6 在 AD 相关神经保护途径中的新作用”
基本信息
- 批准号:10353397
- 负责人:
- 金额:$ 97.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:ATF6 geneAcuteAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloidAmyloid FibrilsAmyloid beta-ProteinAmyloid depositionAstrocytesAttenuatedBehaviorBehavioralBioenergeticsBipolar DisorderBrainCell DeathCell SurvivalCellsChinese populationChronicCognitionCognitiveCognitive deficitsCollectionColor blindnessComplexDataDefectDementiaDepositionDevelopmentDiseaseDisease ProgressionElectrophysiology (science)Endoplasmic ReticulumEnterobacteria phage P1 Cre recombinaseEventFunctional disorderGRP78 geneGRP94Gene ExpressionGenetic ModelsGenetic PolymorphismGenetic TranscriptionGolgi ApparatusGrantHippocampus (Brain)HumanImmunohistochemistryImpaired cognitionImpairmentIndividualInduced pluripotent stem cell derived neuronsInositolLinkMeasuresMediatingMemoryMessenger RNAMetabolismMicrogliaMolecular ChaperonesMusMutationNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeurogliaNeuronsNeurophysiology - biologic functionNuclear TranslocationOnset of illnessOrganoidsPathogenesisPathogenicityPathologicPathologyPathway interactionsPatientsPharmacologyPhenotypePhosphorylationPhosphotransferasesPhysiologicalProductionPromoter RegionsPropertyProteinsRNA SplicingReportingRetinaRetinal ConeRoleSenile PlaquesSignal PathwaySignal TransductionStressSumSynapsesSynaptic PotentialsSynaptic plasticityTamoxifenTestingThinnessTransgenic MiceTransgenic OrganismsVariantVertebral columnXBP1 geneabeta accumulationabeta oligomerachromatopsiaactivating transcription factorage relatedarmbehavioral phenotypingbrain tissuecell typecognitive functiondensityendoplasmic reticulum stressextracellulargain of functionimprovedinsightloss of functionmRNA ExpressionmRNA sequencingmisfolded proteinmouse modelneuron developmentneuron lossneuroprotectionnovelpreventprotein degradationprotein expressionprotein foldingprotein misfoldingproteostasisproteotoxicityresponsesensorsmall moleculesynaptic functiontau Proteinstau aggregationtooltranscription factor
项目摘要
PROJECT SUMMARY
Alzheimer’s Disease (AD) is the most common form of dementia, characterized by misfolding and
aggregation of specific proteins which manifest in pathological features including neuronal loss, cognitive decline
and histopathological hallmarks such as the accumulation of amyloid plaques and neurofibrillary tangles in the
brain. Amyloid plaques comprise extracellular deposits of amyloid-b (Ab) aggregates, where Aβ oligomers are
thought to be proteotoxic to neuronal function. Numerous studies have demonstrated that AD-associated
proteotoxicity triggers an adaptive unfolded protein response (UPR) which attempts to restore proteostatic
dysfunction due to accumulation of misfolded proteins in the endoplasmic reticulum (ER). UPR signaling is
mediated through PERK/eIF2a, IRE1/XBP1, and ATF6 sensor pathways; relative contributions of these signaling
arms to neurodegeneration is complex as they have dual roles in mediating cell survival and cell death.
Elevations in PERK/phosphorylated eIF2a, XBP1 mRNA splicing, and increased levels of ER chaperones such
as BiP/GRP78, GRP94 and PDI in human AD brain strongly suggests chronic activation of ER stress is evident
in human AD pathology. Further, a polymorphism previously linked to bipolar disorders within the XBP1 promoter
region was linked to increased AD risk in Chinese populations. Although it has been established that UPR
pathways are activated in disorders such as AD, it is not clear whether UPR pathways confer neuroprotective
effects, or if their activation can contribute to pathogenesis.
Potential neuroprotective effects of the ATF6 pathway in neurodegeneration have remained particularly
elusive. ATF6 functions as an ER stress sensor and transcription factor that promotes expression of genes that
enhance proper protein folding via increased production of ER chaperones and increased degradation of
misfolded proteins. We present new evidence that ATF6 is essential for synaptic function, as Atf6-/- mice display
cognitive and behavioral defects associated with reduced synaptic spine density. Further, exogenous expression
of the active ATF6 form suppressed accumulation of amyloid fibrils in a murine model of AD. These results
provide strong evidence that ATF6 activation may have a physiological role in synaptic activity and cognitive
behavior, and acute ATF6 activation can confer neuroprotective effects with AD-associated proteotoxicity. In the
proposed study, our efforts will be focused on elucidating potential neuroprotective effects of ATF6 on neuronal
and synaptic function, and differentiate potential roles for ATF6 in neurons and microglia. Given the effects of
ATF6 on attenuating Aβ plaque formation, we will characterize proteins that are particularly susceptible to
proteostatic dysfunction in AD. We will also characterize the effects of ATF6 mutational variants identified in
human Achromatopsia patients on neuronal function, and determine whether pharmacological activation of ATF6
is protective in AD. The sum of these results will implicate a novel role for ATF6 in neuronal/synaptic function,
and provide insight into potential strategies to reverse synaptic impairment through enhancing UPR function.
项目摘要
阿尔茨海默氏病(AD)是痴呆症的最常见形式,其特征是错误形式和
特定蛋白质的聚集在病理特征中表现出包括神经元丧失,认知能力下降
以及组织病理学的标志,例如淀粉样蛋白斑块的积累和神经著名缠结
大脑。
许多研究表明,这是相关的
蛋白毒素触发自适应展开的蛋白质反应(UPR),该蛋白质反应试图恢复蛋白抑制剂
由于内质网(ER)中错误折叠蛋白的积累而引起的功能障碍
介导的Throgh Perk/EIF2A,IRE1/XBP1和ATF6传感器途径;
神经变性的臂很复杂,因为它们在介导细胞存活和细胞死亡中具有双重作用。
PERK/PERK/磷酸化EIF2A,XBP1 mRNA剪接和ER伴侣水平的升高
正如BIP/GRP78一样
在人类AD病理学中,多态性先前与XBP1启动子中
区域与中国人口的AD风险增加有关。
途径在AD等疾病中被激活,尚不清楚UPR途径是否赋予神经保护作用
影响,或者它们的激活可能有助于发病机理。
ATF6途径在神经退行性中的潜在神经保护作用已特别补充
难以捉摸。
通过增加ER伴侣的产生和增加的降解来增强蛋白质折叠
我们提供了错误折叠的蛋白质。
与突触脊柱密度相关的认知和行为缺陷
活跃的ATF6形式抑制了AD鼠模型中淀粉样蛋白纤维的积累
提供有力的证据表明ATF6激活可能在突触活动和认知中具有生理作用
行为和急性ATF6激活可以赋予您与AD相关的蛋白毒性的神经保护作用
支撑研究,我们的努力将集中于ATF6对神经元的ElucididatiDatiDatil神经孕妇的作用
并在神经元和小胶质细胞中区分了ATF6的潜在作用。
ATF6在减弱Aβ斑块形成时,我们将表征特别令人震惊的蛋白质
AD中的蛋白质功能障碍。
人类嗜性瘤患者的神经元功能,并确定ATF6的药理学是否激活
在AD中具有保护性。
并洞悉通过增强UPR功能的潜在策略来逆转损害损害。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Yikai Huang其他文献
Timothy Yikai Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Yikai Huang', 18)}}的其他基金
Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis
阐明 SORLA 在调节 AD 发病机制中的小胶质细胞相关作用
- 批准号:
10455261 - 财政年份:2022
- 资助金额:
$ 97.48万 - 项目类别:
Characterizing a potential role for TREM2 in modulating tau pathogenesis in response to Abeta
表征 TREM2 在响应 Abeta 调节 tau 发病机制中的潜在作用
- 批准号:
10360474 - 财政年份:2021
- 资助金额:
$ 97.48万 - 项目类别:
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
“UPR 成分 ATF6 在 AD 相关神经保护途径中的新作用”
- 批准号:
10132964 - 财政年份:2019
- 资助金额:
$ 97.48万 - 项目类别:
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
“UPR 成分 ATF6 在 AD 相关神经保护途径中的新作用”
- 批准号:
10563219 - 财政年份:2019
- 资助金额:
$ 97.48万 - 项目类别:
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD
阿尔茨海默病 (AD) 风险基因 SORLA 在 AD 神经保护中的新作用
- 批准号:
10404609 - 财政年份:2018
- 资助金额:
$ 97.48万 - 项目类别:
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD
阿尔茨海默病 (AD) 风险基因 SORLA 在 AD 神经保护中的新作用
- 批准号:
9788245 - 财政年份:2018
- 资助金额:
$ 97.48万 - 项目类别:
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD
阿尔茨海默病 (AD) 风险基因 SORLA 在 AD 神经保护中的新作用
- 批准号:
9925791 - 财政年份:2018
- 资助金额:
$ 97.48万 - 项目类别:
Molecular pathobiology of soluble TREM2 in Alzheimer's disease
可溶性 TREM2 在阿尔茨海默病中的分子病理学
- 批准号:
10737172 - 财政年份:2017
- 资助金额:
$ 97.48万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
利多卡因通过Nav1.8通道调控白介素31表达影响特应性皮炎急性瘙痒的机制
- 批准号:82373490
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
超急性期免疫表征影响脑卒中预后研究
- 批准号:
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:
eIF2α/ATF3通路调控CPT1α影响线粒体稳态在急性肾损伤慢性化中的机制研究
- 批准号:82300838
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of retinal homeostasis and disease by Fic-mediated AMPylation
Fic 介导的 AMPylation 对视网膜稳态和疾病的调节
- 批准号:
10741035 - 财政年份:2023
- 资助金额:
$ 97.48万 - 项目类别:
The role of LPCAT3 in pathogenesis of diabetic cardiomyopathy
LPCAT3在糖尿病心肌病发病机制中的作用
- 批准号:
10867671 - 财政年份:2023
- 资助金额:
$ 97.48万 - 项目类别:
The ER-mitochondria interface in astrocytes during METH exposure and HIV-1 infection
METH 暴露和 HIV-1 感染期间星形胶质细胞中的 ER-线粒体界面
- 批准号:
10259195 - 财政年份:2021
- 资助金额:
$ 97.48万 - 项目类别:
The ER-mitochondria interface in astrocytes during METH exposure and HIV-1 infection
METH 暴露和 HIV-1 感染期间星形胶质细胞中的 ER-线粒体界面
- 批准号:
10401315 - 财政年份:2021
- 资助金额:
$ 97.48万 - 项目类别:
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
“UPR 成分 ATF6 在 AD 相关神经保护途径中的新作用”
- 批准号:
10132964 - 财政年份:2019
- 资助金额:
$ 97.48万 - 项目类别: